|
ALT
|
Altimmune, Inc.
|
8.19%
|
US
|
NASDAQ
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
6.32%
|
US
|
NASDAQ
|
|
ADPT
|
Adaptive Biotechnologies Corporation
|
5.76%
|
US
|
NASDAQ
|
|
ZLAB
|
Zai Lab Limited
|
4.97%
|
US
|
NASDAQ
|
|
VALT
|
ETFMG Sit Ultra Short ETF
|
4.97%
|
US
|
AMEX
|
|
ABCL
|
AbCellera Biologics Inc.
|
4.51%
|
US
|
NASDAQ
|
|
BIO
|
Bio-Rad Laboratories, Inc.
|
4.23%
|
US
|
NYSE
|
|
DGX
|
Quest Diagnostics Incorporated
|
4.16%
|
US
|
NYSE
|
|
LH
|
Laboratory Corporation of America Holdings
|
4.08%
|
US
|
NYSE
|
|
MRNA
|
Moderna, Inc.
|
3.93%
|
US
|
NASDAQ
|
|
QDEL
|
Quidel Corporation
|
3.89%
|
US
|
NASDAQ
|
|
PCVX
|
Vaxcyte, Inc.
|
3.75%
|
US
|
NASDAQ
|
|
BNTX
|
BioNTech SE
|
3.53%
|
US
|
NASDAQ
|
|
VIR
|
Vir Biotechnology, Inc.
|
3.44%
|
US
|
NASDAQ
|
|
IMCR
|
Immunocore Holdings plc
|
2.48%
|
US
|
NASDAQ
|
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
2.25%
|
US
|
NASDAQ
|
|
VIVO
|
Meridian Bioscience Inc.
|
1.51%
|
US
|
NASDAQ
|
|
DVAX
|
Dynavax Technologies Corporation
|
1.36%
|
US
|
NASDAQ
|
|
CVAC
|
CureVac N.V.
|
1.25%
|
US
|
NASDAQ
|
|
ENTA
|
Enanta Pharmaceuticals, Inc.
|
1.00%
|
US
|
NASDAQ
|